GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&:beta): (IC = 0.5 μM). This compound acts as an alkylating agent that is
GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&:beta): (IC = 0.5 μM). This compound acts as an alkylating agent that is
GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&:beta): (IC = 0.5 μM). This compound acts as an alkylating agent that is
GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&:beta): (IC = 0.5 μM). This compound acts as an alkylating agent that is
GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&:beta): (IC = 0.5 μM). This compound acts as an alkylating agent that is
GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&:beta): (IC = 0.5 μM). This compound acts as an alkylating agent that is
GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&:beta): (IC = 0.5 μM). This compound acts as an alkylating agent that is
GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&:beta): (IC = 0.5 μM). This compound acts as an alkylating agent that is
Rabbit anti Human Osteopontin Antibody, Polyclonal, could be used for WB, IHC and so on.
Application
WB: 0.01-3 µg/mL
IHC: 5-30 µg/mL
Protein Function
Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix.
Rabbit anti Human Osteopontin Antibody, Polyclonal, could be used for WB, IHC and so on.
Application
WB: 0.01-3 µg/mL
IHC: 5-30 µg/mL
Protein Function
Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix.
Rabbit anti Human Osteopontin Antibody, Polyclonal, could be used for WB, IHC and so on.
Application
WB: 0.01-3 µg/mL
IHC: 5-30 µg/mL
Protein Function
Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix.
Rabbit anti Human Osteopontin Antibody, Polyclonal, could be used for WB, IHC and so on.
Application
WB: 0.01-3 µg/mL
IHC: 5-30 µg/mL
Protein Function
Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix.
Rabbit anti Human Osteopontin Antibody, Polyclonal, could be used for WB, IHC and so on.
Application
WB: 0.01-3 µg/mL
IHC: 5-30 µg/mL
Protein Function
Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix.
Rabbit anti Human Osteopontin Antibody, Polyclonal, could be used for WB, IHC and so on.
Application
WB: 0.01-3 µg/mL
IHC: 5-30 µg/mL
Protein Function
Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix.
Rabbit anti Human Osteopontin Antibody, Polyclonal, could be used for WB, IHC and so on.
Application
WB: 0.01-3 µg/mL
IHC: 5-30 µg/mL
Protein Function
Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix.
Rabbit anti Human Osteopontin Antibody, Polyclonal, could be used for WB, IHC and so on.
Application
WB: 0.01-3 µg/mL
IHC: 5-30 µg/mL
Protein Function
Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix.